ClinicalTrials.govpublic full text
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
relapsing multiple sclerosis, multiple sclerosis, ms, rms, rituximab, cladribine, probe, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877312
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.